Grünenthal’s 2019/20 annual report shares insights into our record-breaking year Grünenthal achieved the best ever financial performance in 2019 with EBITDA growth exceeding 60 …

Mar 25, 2024 · [1]Based on internal analysis by Grünenthal GmbH using data from IQVIA Forecast Link Q3 2023 release forecast data, with historical data up to and including Q3 2023 …

Grünenthal reports 2021 full-year results of €1.5 billion in net revenues with double-digit growth and major investments in portfolio and pipeline.

Use our commercial database of more than 120 million business records & industry directory for company research & industry analysis. Start sales research here.

Mar 27, 2025 · EQS-News: Grünenthal GmbH / Key word (s): Annual Results Grünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in …

Our NOP compound became our first proprietary Grünenthal com-pound to enter clinical development since 2017. It is the frontrun-ner of our peripheral Nociceptin/orphanin peptide …

Grünenthal is a global leader in pain management and related diseases.

Discover details on Grunenthal GmbH’s annual and quarterly financial performance covering key metrics like revenue, net income, growth ratios, equity ratios, profitability ratios, cost ratios, …

Strategy for growth Grünenthal’s portfolio of established medicines has outper-formed its respective markets. Since 2017, we have invested more than €2 billion in successful …

Mar 27, 2023 · Grünenthal meldet für das Geschäftsjahr 2022 einen Rekordumsatz und -gewinn sowie große Fortschritte bei der Entwicklung neuer Arzneimittelkandidaten

Mar 25, 2024 · EQS-News: Grünenthal GmbH / Key word (s): Annual Results Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions …

Aachen, Germany, 11 December 2024 – Grünenthal GmbH (“Grünenthal”), a pharmaceutical company specialized in treatment of pain, today announced that Grünenthal has entered into a …

Our virtual company showcase provides information about our key objectives and activities, recent business development highlights, and financial performance.

Mar 30, 2022 · DGAP-News: Grünenthal GmbH / Key word(s): Annual Results30.03.2022 / 10:35 The issuer is solely responsible for the content of this announcement.Grünenthal achieves …